Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CTS | STRA |
|---|---|---|
| Price | $61.61 | $79.28 |
| Change today | ▲ 0.02% | ▼ 0.55% |
| Market cap | $1.76B | $1.76B |
| Return, 3 months | +4.2% | -4.9% |
| Return, year to date | +44.0% | +1.1% |
| Return, 1 year | +54.1% | -2.6% |
| P/E (TTM) | 25.8 | 13.2 |
| P/B | 3.1 | 1.1 |
| P/E percentile vs own 5y | – | 1st |
| Dividend yield | 0.26% | 3.03% |
| Revenue growth (YoY, latest qtr) | – | +4.0% |
| Net profit growth (YoY) | – | +12.4% |
| Gross margin | – | 49.0% |
| Operating margin | – | 15.5% |
| Net margin | – | 10.0% |
| Return on equity | – | – |
| Analyst target vs. price | +19.3% | +21.9% |
| Analyst buy share | 100% | 67% |
| RSI (14) | 66 | 49 |
| 30-day volatility | 19.9% | 24.5% |
| Max drawdown, 1 year | -20.3% | -15.7% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
